RT @MeralElRamahiMD: âï¸JUNIPERA: RCT of SEC in active ERA & JPsA (2-18yo, most on MTX) -Tx . (TP)1: SEC 75/100 m

Social Author Image

https://pbs.twimg.com/profile_images/908324013566513153/YdK61O5C.jpg

Tweet Author

Social Author Name

Meral K. El Ramahi, MD

Tweet Content

⭐️JUNIPERA: RCT of SEC in active ERA & JPsA (2-18yo, most on MTX) -Tx . (TP)1: SEC 75/100 mg till wk 12 -TP2: cont SEC or switch to PBO till wk 104 ⭐️SEC efficacious on JIA ACR30/70 ⭐️74% w/ resolution of enthes ⭐️Median T2flare in PBO in TP2 = 453d LB0004 #EULAR2021 @Rheumnow https://t.co/JsG2pXz9r6

Show on Archive Page

On

Display in Search Results

On

PDQ

Off

Topics

RT @MeralElRamahiMD: âï¸JUNIPERA: RCT of SEC in active ERA & JPsA (2-18yo, most on MTX) -Tx . (TP)1: SEC 75/100 m

Do you get our email newsletter?

RT @MeralElRamahiMD: â­ï¸JUNIPERA: RCT of SEC in active ERA &amp; JPsA (2-18yo, most on MTX) -Tx . (TP)1: SEC 75/100 m

RT @MeralElRamahiMD: âï¸JUNIPERA: RCT of SEC in active ERA & JPsA (2-18yo, most on MTX) -Tx . (TP)1: SEC 75/100 m